Catheter Duration and Risk of CLA-BSI in Neonates with PICCs
Overview
Affiliations
Objective: To determine whether the risk of central line-associated bloodstream infections (CLA-BSIs) remained constant over the duration of peripherally inserted central venous catheters (PICCs) in high-risk neonates.
Patient And Methods: We performed a retrospective cohort study of NICU patients who had a PICC inserted between January 1, 2006, and December 31, 2008. A Poisson regression model with linear spline terms to model time since PICC insertion was used to evaluate potential changes in the risk of CLA-BSI while adjusting for other variables.
Results: Six hundred eighty-three neonates were eligible for analysis. There were 21 CLA-BSIs within a follow-up period of 10 470 catheter-days. The incidence of PICC-associated CLA-BSI was 2.01 per 1 000 catheter-days (95% confidence interval [CI]: 1.24-3.06). The incidence rate of CLA-BSIs increased by 14% per day during the first 18 days after PICC insertion (incidence rate ratio [IRR]: 1.14 [95% CI: 1.04-1.25]). From days 19 through 35 after PICC insertion, the trend reversed (IRR: 0.8 [95% CI: 0.66-0.96]). From days 36 through 60 after PICC insertion, the incidence rate of CLA-BSI again increased by 33% per day (IRR: 1.33 [95% CI: 1.12-1.57]). There was no statistically significant association between the risk of CLA-BSI and gestational age groups, birth weight groups, or chronological age groups.
Conclusions: Our data suggest that catheter duration is an important risk factor for PICC-associated CLA-BSI in the NICU. A significant daily increase in the risk of CLA-BSI after 35 days may warrant PICC replacement if intravascular access is necessary beyond that period.
Pitiriga V, Campos E, Bakalis J, Saroglou G, Tsakris A Antibiotics (Basel). 2024; 13(7).
PMID: 39061314 PMC: 11273596. DOI: 10.3390/antibiotics13070632.
Zini T, Corso L, Mazzi C, Baraldi C, Nieddu E, Rinaldi L Children (Basel). 2024; 11(4).
PMID: 38671612 PMC: 11048839. DOI: 10.3390/children11040395.
Barone G, DAndrea V, Ancora G, Cresi F, Maggio L, Capasso A Eur J Pediatr. 2023; 182(8):3385-3395.
PMID: 37195350 DOI: 10.1007/s00431-023-04984-4.
Barrigah-Benissan K, Ory J, Simon C, Loubet P, Martin A, Beregi J Antimicrob Resist Infect Control. 2023; 12(1):5.
PMID: 36717942 PMC: 9885663. DOI: 10.1186/s13756-023-01209-z.
Baker M, Bhattarai B, Johnson P, Wade C, Micetic B, Mody K J Pediatr Pharmacol Ther. 2022; 27(8):715-719.
PMID: 36415766 PMC: 9674359. DOI: 10.5863/1551-6776-27.8.715.